| NDC Code | 16729-250-03 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-250-03) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 16729-250 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bendamustine Hydrochloride |
|---|
| Non-Proprietary Name | Bendamustine Hydrochloride |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20221207 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA205574 |
|---|
| Manufacturer | Accord Healthcare, Inc. |
|---|
| Substance Name | BENDAMUSTINE HYDROCHLORIDE |
|---|
| Strength | 25 |
|---|
| Strength Unit | mg/5mL |
|---|
| Pharmacy Classes | Alkylating Activity [MoA], Alkylating Drug [EPC] |
|---|